Literature DB >> 2030910

The human ETS1 gene: genomic structure, promoter characterization and alternative splicing.

C L Jorcyk1, D K Watson, G J Mavrothalassitis, T S Papas.   

Abstract

Genomic clones encompassing the human ETS1 gene were isolated and utilized to define its molecular organization. This gene consists of eight exons spanning over 60 kb. The 5' end of the human ETS1 gene was subcloned and characterized. S1 nuclease, primer extension and RNAase protection analyses of human mRNAs showed multiple transcription initiation sites. DNA sequence analysis indicated a high G + C content in the promoter region and the absence of either a 'TATA' box or a 'CAAT' box. Six consensus recognition sequences for the transcription factor SP1, two AP1 consensus sequences and one consensus AP2 recognition sequence were identified, as well as two GC elements with dyad symmetry. A palindromic region similar to the serum response element of the c-fos gene and two octamer consensus recognition sequences were located upstream of the promoter region. A series of promoter deletion constructs positioned upstream from the bacterial chloramphenicol acetyl transferase gene were transfected into HeLa cells and their functional promoter activity assayed. The deletion constructs identified the 5' boundary for maximum promoter activity at 486 bp upstream of the first initiation site and suggest possible positive and negative regulatory regions. Polymerase chain reaction analysis of ETS1 cDNA identified several amplified products, indicating alternative splicing. In addition to the presence of mRNA products lacking exon VII, products lacking exon IV, as well as ones lacking both exons IV and VII, were found.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2030910

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  26 in total

1.  Isolation of a cellular factor that can reactivate latent HIV-1 without T cell activation.

Authors:  Hung-Chih Yang; Lin Shen; Robert F Siliciano; Joel L Pomerantz
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-31       Impact factor: 11.205

2.  Regulation of the transcription factor Ets-1 by DNA-mediated homo-dimerization.

Authors:  Ekaterina P Lamber; Laurent Vanhille; Larissa C Textor; Galina S Kachalova; Michael H Sieweke; Matthias Wilmanns
Journal:  EMBO J       Date:  2008-06-19       Impact factor: 11.598

3.  Structure of the Ets-1 pointed domain and mitogen-activated protein kinase phosphorylation site.

Authors:  C M Slupsky; L N Gentile; L W Donaldson; C D Mackereth; J J Seidel; B J Graves; L P McIntosh
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-13       Impact factor: 11.205

4.  The p42 variant of ETS1 protein rescues defective Fas-induced apoptosis in colon carcinoma cells.

Authors:  R Li; H Pei; T Papas
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

5.  ETS1 suppresses tumorigenicity of human colon cancer cells.

Authors:  H Suzuki; V Romano-Spica; T S Papas; N K Bhat
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-09       Impact factor: 11.205

6.  During in vivo maturation of eukaryotic nuclear mRNA, splicing yields excised exon circles.

Authors:  B Bailleul
Journal:  Nucleic Acids Res       Date:  1996-03-15       Impact factor: 16.971

7.  ets-1 in astrocytes: expression and transmitter-evoked phosphorylation.

Authors:  L F Fleischman; L Holtzclaw; J T Russell; G Mavrothalassitis; R J Fisher
Journal:  Mol Cell Biol       Date:  1995-02       Impact factor: 4.272

8.  Inverse splicing of a group II intron.

Authors:  K A Jarrell
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-15       Impact factor: 11.205

9.  Real-time DNA binding measurements of the ETS1 recombinant oncoproteins reveal significant kinetic differences between the p42 and p51 isoforms.

Authors:  R J Fisher; M Fivash; J Casas-Finet; J W Erickson; A Kondoh; S V Bladen; C Fisher; D K Watson; T Papas
Journal:  Protein Sci       Date:  1994-02       Impact factor: 6.725

10.  Identification and dissection of a key enhancer mediating cranial neural crest specific expression of transcription factor, Ets-1.

Authors:  Meyer Barembaum; Marianne E Bronner
Journal:  Dev Biol       Date:  2013-08-19       Impact factor: 3.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.